Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Nilotinib | 0.1 | uM | 3 | 156.25 | 49.48 | 71.00 | 103.75 | 0.6843 | 0.4022 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 156.25 | 49.48 | 89.00 | 103.75 | 0.8578 | 0.7326 |
| BT-20 | PLX-4720 | 1 | uM | 3 | 156.25 | 49.48 | 126.00 | 103.75 | 1.2145 | 1.3990 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 3 | 156.25 | 49.48 | 177.00 | 103.75 | 1.7060 | 2.2976 |
| BT-20 | Nilotinib | 10 | uM | 3 | 156.25 | 49.48 | 484.00 | 103.75 | 4.6651 | 7.4562 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 156.25 | 49.48 | 111.00 | 103.75 | 1.0699 | 1.1305 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 156.25 | 49.48 | 52.00 | 103.75 | 0.5012 | 0.0476 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 116.00 | 103.75 | 1.1181 | 1.2203 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 75.00 | 103.75 | 0.7229 | 0.4761 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 81.00 | 103.75 | 0.7807 | 0.5863 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 85.00 | 103.75 | 0.8193 | 0.6596 | |
| BT-20 | Etoposide | 1 | uM | 3 | 156.25 | 49.48 | 96.00 | 103.75 | 0.9253 | 0.8598 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 3 | 156.25 | 49.48 | 81.00 | 103.75 | 0.7807 | 0.5863 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 77.00 | 103.75 | 0.7422 | 0.5129 | |
| BT-20 | NVP-TAE684 | 10 | uM | 3 | 156.25 | 49.48 | 37.00 | 103.75 | 0.3566 | -0.2382 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 156.25 | 49.48 | 153.00 | 103.75 | 1.4747 | 1.8771 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 3 | 156.25 | 49.48 | 136.00 | 103.75 | 1.3108 | 1.5768 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 156.25 | 49.48 | 88.00 | 103.75 | 0.8482 | 0.7143 |
| BT-20 | PLX-4720 | 3.1623 | uM | 3 | 156.25 | 49.48 | 149.00 | 103.75 | 1.4361 | 1.8067 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 156.25 | 49.48 | 87.00 | 103.75 | 0.8386 | 0.6961 |
| BT-20 | Etoposide | 0.1 | uM | 3 | 156.25 | 49.48 | 155.00 | 103.75 | 1.4940 | 1.9123 |
| BT-20 | Nilotinib | 0.031623 | uM | 3 | 156.25 | 49.48 | 90.00 | 103.75 | 0.8675 | 0.7508 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 116.00 | 103.75 | 1.1181 | 1.2203 | |
| BT-20 | PLX-4720 | 19.9526 | uM | 3 | 156.25 | 49.48 | 79.00 | 103.75 | 0.7615 | 0.5496 |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 3 | 156.25 | 49.48 | 106.00 | 103.75 | 1.0217 | 1.0406 |